Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer

Corresponding Author

Department of Medicine, Division of Medical Oncology, Anschutz Medical Campus, University of Colorado, Aurora, Colorado, USA

Correspondence Aik-Choon Tan, Moffitt, Department of Biostatistics and Bioinformatics, 12902 Magnolia Dr, MRC, 2nd Floor, Tampa, FL 33612, USA.

Peter Kabos, University of Colorado Denver, Department of Medicine, 12801 E 17th Ave, RC1 South, M.S. 8117, Aurora CO 80045, USA.

View original article

0 0 0 0 0 0 0

Comments (0)